People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Popular medications, such as Ozempic, Mounjaro and Wegovy, are known as GLP-1 agonists as they mimic the natural GLP-1s ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Shaughna Phillips reveals how she’s gone from a size 18 to an 8, why she’s shunned Ozempic and how her daughter was her biggest motivation.

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...